ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Antiretroviral Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-14Y14466
Home | Market Reports | Health| Reproductive Health
Global HIV Antiretroviral Drug Market Research Report 2023
BUY CHAPTERS

Global HIV Antiretroviral Drug Market Research Report 2025

Code: QYRE-Auto-14Y14466
Report
March 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
AbbVie
Merck
GSK
Bristol Myers Squibb Company
Theratechnologies
Roche Holding AG
Teva Pharmaceuticals
Pfizer Inc
Frontier Biotechnologies
Shionogi
Julphar Bangladesh
Mylan Pharmaceuticals Inc.
Genentech Inc
Boehringer Ingelheim
Cipla Ltd
MSD
Abbott
Johnson & Johnson
Biocon Ltd.
Affine Formulations Limited
Ipca Laboratories
Natco Pharma
Beacon Pharmaceuticals
ViiV Healthcare(GlaxoSmithKline)

HIV Antiretroviral Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

HIV Antiretroviral Drug Market

HIV Antiretroviral Drug Market

The global market for HIV Antiretroviral Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for HIV Antiretroviral Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Antiretroviral Drug.
The HIV Antiretroviral Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Antiretroviral Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Antiretroviral Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of HIV Antiretroviral Drug Market Report

Report Metric Details
Report Name HIV Antiretroviral Drug Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ViiV Healthcare(GlaxoSmithKline), Gilead Sciences, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG, Teva Pharmaceuticals, Pfizer, Frontier Biotechnologies, Shionogi, Julphar Bangladesh, Mylan Pharmaceuticals Inc., Genentech, Inc., Boehringer Ingelheim, Cipla, MSD, Abbott, Johnson & Johnson, Biocon Limited, Affine Formulations Limited, IPCA Laboratories, Natco Pharma, Beacon Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of HIV Antiretroviral Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Antiretroviral Drug Market report?

Ans: The main players in the HIV Antiretroviral Drug Market are ViiV Healthcare(GlaxoSmithKline), Gilead Sciences, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG, Teva Pharmaceuticals, Pfizer, Frontier Biotechnologies, Shionogi, Julphar Bangladesh, Mylan Pharmaceuticals Inc., Genentech, Inc., Boehringer Ingelheim, Cipla, MSD, Abbott, Johnson & Johnson, Biocon Limited, Affine Formulations Limited, IPCA Laboratories, Natco Pharma, Beacon Pharmaceuticals

What are the Application segmentation covered in the HIV Antiretroviral Drug Market report?

Ans: The Applications covered in the HIV Antiretroviral Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the HIV Antiretroviral Drug Market report?

Ans: The Types covered in the HIV Antiretroviral Drug Market report are Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Others

Recommended Reports

Antiviral Drug Markets

Pharmaceutical Testing & Screening

Therapeutic & Specialty Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Antiretroviral Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Protease Inhibitors
1.2.5 Fusion Inhibitors
1.2.6 Others
1.3 Market by Application
1.3.1 Global HIV Antiretroviral Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Antiretroviral Drug Market Perspective (2020-2031)
2.2 Global HIV Antiretroviral Drug Growth Trends by Region
2.2.1 Global HIV Antiretroviral Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HIV Antiretroviral Drug Historic Market Size by Region (2020-2025)
2.2.3 HIV Antiretroviral Drug Forecasted Market Size by Region (2026-2031)
2.3 HIV Antiretroviral Drug Market Dynamics
2.3.1 HIV Antiretroviral Drug Industry Trends
2.3.2 HIV Antiretroviral Drug Market Drivers
2.3.3 HIV Antiretroviral Drug Market Challenges
2.3.4 HIV Antiretroviral Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Antiretroviral Drug Players by Revenue
3.1.1 Global Top HIV Antiretroviral Drug Players by Revenue (2020-2025)
3.1.2 Global HIV Antiretroviral Drug Revenue Market Share by Players (2020-2025)
3.2 Global HIV Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HIV Antiretroviral Drug Revenue
3.4 Global HIV Antiretroviral Drug Market Concentration Ratio
3.4.1 Global HIV Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Antiretroviral Drug Revenue in 2024
3.5 Global Key Players of HIV Antiretroviral Drug Head office and Area Served
3.6 Global Key Players of HIV Antiretroviral Drug, Product and Application
3.7 Global Key Players of HIV Antiretroviral Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Antiretroviral Drug Breakdown Data by Type
4.1 Global HIV Antiretroviral Drug Historic Market Size by Type (2020-2025)
4.2 Global HIV Antiretroviral Drug Forecasted Market Size by Type (2026-2031)
5 HIV Antiretroviral Drug Breakdown Data by Application
5.1 Global HIV Antiretroviral Drug Historic Market Size by Application (2020-2025)
5.2 Global HIV Antiretroviral Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HIV Antiretroviral Drug Market Size (2020-2031)
6.2 North America HIV Antiretroviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HIV Antiretroviral Drug Market Size by Country (2020-2025)
6.4 North America HIV Antiretroviral Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Antiretroviral Drug Market Size (2020-2031)
7.2 Europe HIV Antiretroviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HIV Antiretroviral Drug Market Size by Country (2020-2025)
7.4 Europe HIV Antiretroviral Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Antiretroviral Drug Market Size (2020-2031)
8.2 Asia-Pacific HIV Antiretroviral Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HIV Antiretroviral Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific HIV Antiretroviral Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Antiretroviral Drug Market Size (2020-2031)
9.2 Latin America HIV Antiretroviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HIV Antiretroviral Drug Market Size by Country (2020-2025)
9.4 Latin America HIV Antiretroviral Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Antiretroviral Drug Market Size (2020-2031)
10.2 Middle East & Africa HIV Antiretroviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HIV Antiretroviral Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa HIV Antiretroviral Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ViiV Healthcare(GlaxoSmithKline)
11.1.1 ViiV Healthcare(GlaxoSmithKline) Company Details
11.1.2 ViiV Healthcare(GlaxoSmithKline) Business Overview
11.1.3 ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Introduction
11.1.4 ViiV Healthcare(GlaxoSmithKline) Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.1.5 ViiV Healthcare(GlaxoSmithKline) Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences HIV Antiretroviral Drug Introduction
11.2.4 Gilead Sciences Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. HIV Antiretroviral Drug Introduction
11.3.4 AbbVie Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.3.5 AbbVie Inc. Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co HIV Antiretroviral Drug Introduction
11.4.4 Merck & Co Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.4.5 Merck & Co Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK HIV Antiretroviral Drug Introduction
11.5.4 GSK Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.5.5 GSK Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company HIV Antiretroviral Drug Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Theratechnologies Inc.
11.7.1 Theratechnologies Inc. Company Details
11.7.2 Theratechnologies Inc. Business Overview
11.7.3 Theratechnologies Inc. HIV Antiretroviral Drug Introduction
11.7.4 Theratechnologies Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.7.5 Theratechnologies Inc. Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG HIV Antiretroviral Drug Introduction
11.8.4 Roche Holding AG Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.8.5 Roche Holding AG Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Details
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals HIV Antiretroviral Drug Introduction
11.9.4 Teva Pharmaceuticals Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer HIV Antiretroviral Drug Introduction
11.10.4 Pfizer Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Frontier Biotechnologies
11.11.1 Frontier Biotechnologies Company Details
11.11.2 Frontier Biotechnologies Business Overview
11.11.3 Frontier Biotechnologies HIV Antiretroviral Drug Introduction
11.11.4 Frontier Biotechnologies Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.11.5 Frontier Biotechnologies Recent Development
11.12 Shionogi
11.12.1 Shionogi Company Details
11.12.2 Shionogi Business Overview
11.12.3 Shionogi HIV Antiretroviral Drug Introduction
11.12.4 Shionogi Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.12.5 Shionogi Recent Development
11.13 Julphar Bangladesh
11.13.1 Julphar Bangladesh Company Details
11.13.2 Julphar Bangladesh Business Overview
11.13.3 Julphar Bangladesh HIV Antiretroviral Drug Introduction
11.13.4 Julphar Bangladesh Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.13.5 Julphar Bangladesh Recent Development
11.14 Mylan Pharmaceuticals Inc.
11.14.1 Mylan Pharmaceuticals Inc. Company Details
11.14.2 Mylan Pharmaceuticals Inc. Business Overview
11.14.3 Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Introduction
11.14.4 Mylan Pharmaceuticals Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.14.5 Mylan Pharmaceuticals Inc. Recent Development
11.15 Genentech, Inc.
11.15.1 Genentech, Inc. Company Details
11.15.2 Genentech, Inc. Business Overview
11.15.3 Genentech, Inc. HIV Antiretroviral Drug Introduction
11.15.4 Genentech, Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.15.5 Genentech, Inc. Recent Development
11.16 Boehringer Ingelheim
11.16.1 Boehringer Ingelheim Company Details
11.16.2 Boehringer Ingelheim Business Overview
11.16.3 Boehringer Ingelheim HIV Antiretroviral Drug Introduction
11.16.4 Boehringer Ingelheim Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.16.5 Boehringer Ingelheim Recent Development
11.17 Cipla
11.17.1 Cipla Company Details
11.17.2 Cipla Business Overview
11.17.3 Cipla HIV Antiretroviral Drug Introduction
11.17.4 Cipla Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.17.5 Cipla Recent Development
11.18 MSD
11.18.1 MSD Company Details
11.18.2 MSD Business Overview
11.18.3 MSD HIV Antiretroviral Drug Introduction
11.18.4 MSD Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.18.5 MSD Recent Development
11.19 Abbott
11.19.1 Abbott Company Details
11.19.2 Abbott Business Overview
11.19.3 Abbott HIV Antiretroviral Drug Introduction
11.19.4 Abbott Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.19.5 Abbott Recent Development
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Details
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson HIV Antiretroviral Drug Introduction
11.20.4 Johnson & Johnson Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.20.5 Johnson & Johnson Recent Development
11.21 Biocon Limited
11.21.1 Biocon Limited Company Details
11.21.2 Biocon Limited Business Overview
11.21.3 Biocon Limited HIV Antiretroviral Drug Introduction
11.21.4 Biocon Limited Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.21.5 Biocon Limited Recent Development
11.22 Affine Formulations Limited
11.22.1 Affine Formulations Limited Company Details
11.22.2 Affine Formulations Limited Business Overview
11.22.3 Affine Formulations Limited HIV Antiretroviral Drug Introduction
11.22.4 Affine Formulations Limited Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.22.5 Affine Formulations Limited Recent Development
11.23 IPCA Laboratories
11.23.1 IPCA Laboratories Company Details
11.23.2 IPCA Laboratories Business Overview
11.23.3 IPCA Laboratories HIV Antiretroviral Drug Introduction
11.23.4 IPCA Laboratories Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.23.5 IPCA Laboratories Recent Development
11.24 Natco Pharma
11.24.1 Natco Pharma Company Details
11.24.2 Natco Pharma Business Overview
11.24.3 Natco Pharma HIV Antiretroviral Drug Introduction
11.24.4 Natco Pharma Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.24.5 Natco Pharma Recent Development
11.25 Beacon Pharmaceuticals
11.25.1 Beacon Pharmaceuticals Company Details
11.25.2 Beacon Pharmaceuticals Business Overview
11.25.3 Beacon Pharmaceuticals HIV Antiretroviral Drug Introduction
11.25.4 Beacon Pharmaceuticals Revenue in HIV Antiretroviral Drug Business (2020-2025)
11.25.5 Beacon Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Gilead Sciences
AbbVie
Merck
GSK
Bristol Myers Squibb Company
Theratechnologies
Roche Holding AG
Teva Pharmaceuticals
Pfizer Inc
Frontier Biotechnologies
Shionogi
Julphar Bangladesh
Mylan Pharmaceuticals Inc.
Genentech Inc
Boehringer Ingelheim
Cipla Ltd
MSD
Abbott
Johnson & Johnson
Biocon Ltd.
Affine Formulations Limited
Ipca Laboratories
Natco Pharma
Beacon Pharmaceuticals
ViiV Healthcare(GlaxoSmithKline)
List of Tables
 Table 1. Global HIV Antiretroviral Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors
 Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors
 Table 4. Key Players of Protease Inhibitors
 Table 5. Key Players of Fusion Inhibitors
 Table 6. Key Players of Others
 Table 7. Global HIV Antiretroviral Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global HIV Antiretroviral Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global HIV Antiretroviral Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global HIV Antiretroviral Drug Market Share by Region (2020-2025)
 Table 11. Global HIV Antiretroviral Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global HIV Antiretroviral Drug Market Share by Region (2026-2031)
 Table 13. HIV Antiretroviral Drug Market Trends
 Table 14. HIV Antiretroviral Drug Market Drivers
 Table 15. HIV Antiretroviral Drug Market Challenges
 Table 16. HIV Antiretroviral Drug Market Restraints
 Table 17. Global HIV Antiretroviral Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global HIV Antiretroviral Drug Market Share by Players (2020-2025)
 Table 19. Global Top HIV Antiretroviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Antiretroviral Drug as of 2024)
 Table 20. Ranking of Global Top HIV Antiretroviral Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by HIV Antiretroviral Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of HIV Antiretroviral Drug, Headquarters and Area Served
 Table 23. Global Key Players of HIV Antiretroviral Drug, Product and Application
 Table 24. Global Key Players of HIV Antiretroviral Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global HIV Antiretroviral Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global HIV Antiretroviral Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global HIV Antiretroviral Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global HIV Antiretroviral Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global HIV Antiretroviral Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global HIV Antiretroviral Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global HIV Antiretroviral Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global HIV Antiretroviral Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America HIV Antiretroviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America HIV Antiretroviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America HIV Antiretroviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe HIV Antiretroviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe HIV Antiretroviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe HIV Antiretroviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific HIV Antiretroviral Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific HIV Antiretroviral Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific HIV Antiretroviral Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America HIV Antiretroviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America HIV Antiretroviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America HIV Antiretroviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa HIV Antiretroviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa HIV Antiretroviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa HIV Antiretroviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. ViiV Healthcare(GlaxoSmithKline) Company Details
 Table 50. ViiV Healthcare(GlaxoSmithKline) Business Overview
 Table 51. ViiV Healthcare(GlaxoSmithKline) HIV Antiretroviral Drug Product
 Table 52. ViiV Healthcare(GlaxoSmithKline) Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 53. ViiV Healthcare(GlaxoSmithKline) Recent Development
 Table 54. Gilead Sciences Company Details
 Table 55. Gilead Sciences Business Overview
 Table 56. Gilead Sciences HIV Antiretroviral Drug Product
 Table 57. Gilead Sciences Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 58. Gilead Sciences Recent Development
 Table 59. AbbVie Inc. Company Details
 Table 60. AbbVie Inc. Business Overview
 Table 61. AbbVie Inc. HIV Antiretroviral Drug Product
 Table 62. AbbVie Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 63. AbbVie Inc. Recent Development
 Table 64. Merck & Co Company Details
 Table 65. Merck & Co Business Overview
 Table 66. Merck & Co HIV Antiretroviral Drug Product
 Table 67. Merck & Co Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 68. Merck & Co Recent Development
 Table 69. GSK Company Details
 Table 70. GSK Business Overview
 Table 71. GSK HIV Antiretroviral Drug Product
 Table 72. GSK Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 73. GSK Recent Development
 Table 74. Bristol-Myers Squibb Company Company Details
 Table 75. Bristol-Myers Squibb Company Business Overview
 Table 76. Bristol-Myers Squibb Company HIV Antiretroviral Drug Product
 Table 77. Bristol-Myers Squibb Company Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 78. Bristol-Myers Squibb Company Recent Development
 Table 79. Theratechnologies Inc. Company Details
 Table 80. Theratechnologies Inc. Business Overview
 Table 81. Theratechnologies Inc. HIV Antiretroviral Drug Product
 Table 82. Theratechnologies Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 83. Theratechnologies Inc. Recent Development
 Table 84. Roche Holding AG Company Details
 Table 85. Roche Holding AG Business Overview
 Table 86. Roche Holding AG HIV Antiretroviral Drug Product
 Table 87. Roche Holding AG Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 88. Roche Holding AG Recent Development
 Table 89. Teva Pharmaceuticals Company Details
 Table 90. Teva Pharmaceuticals Business Overview
 Table 91. Teva Pharmaceuticals HIV Antiretroviral Drug Product
 Table 92. Teva Pharmaceuticals Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 93. Teva Pharmaceuticals Recent Development
 Table 94. Pfizer Company Details
 Table 95. Pfizer Business Overview
 Table 96. Pfizer HIV Antiretroviral Drug Product
 Table 97. Pfizer Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 98. Pfizer Recent Development
 Table 99. Frontier Biotechnologies Company Details
 Table 100. Frontier Biotechnologies Business Overview
 Table 101. Frontier Biotechnologies HIV Antiretroviral Drug Product
 Table 102. Frontier Biotechnologies Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 103. Frontier Biotechnologies Recent Development
 Table 104. Shionogi Company Details
 Table 105. Shionogi Business Overview
 Table 106. Shionogi HIV Antiretroviral Drug Product
 Table 107. Shionogi Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 108. Shionogi Recent Development
 Table 109. Julphar Bangladesh Company Details
 Table 110. Julphar Bangladesh Business Overview
 Table 111. Julphar Bangladesh HIV Antiretroviral Drug Product
 Table 112. Julphar Bangladesh Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 113. Julphar Bangladesh Recent Development
 Table 114. Mylan Pharmaceuticals Inc. Company Details
 Table 115. Mylan Pharmaceuticals Inc. Business Overview
 Table 116. Mylan Pharmaceuticals Inc. HIV Antiretroviral Drug Product
 Table 117. Mylan Pharmaceuticals Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 118. Mylan Pharmaceuticals Inc. Recent Development
 Table 119. Genentech, Inc. Company Details
 Table 120. Genentech, Inc. Business Overview
 Table 121. Genentech, Inc. HIV Antiretroviral Drug Product
 Table 122. Genentech, Inc. Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 123. Genentech, Inc. Recent Development
 Table 124. Boehringer Ingelheim Company Details
 Table 125. Boehringer Ingelheim Business Overview
 Table 126. Boehringer Ingelheim HIV Antiretroviral Drug Product
 Table 127. Boehringer Ingelheim Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 128. Boehringer Ingelheim Recent Development
 Table 129. Cipla Company Details
 Table 130. Cipla Business Overview
 Table 131. Cipla HIV Antiretroviral Drug Product
 Table 132. Cipla Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 133. Cipla Recent Development
 Table 134. MSD Company Details
 Table 135. MSD Business Overview
 Table 136. MSD HIV Antiretroviral Drug Product
 Table 137. MSD Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 138. MSD Recent Development
 Table 139. Abbott Company Details
 Table 140. Abbott Business Overview
 Table 141. Abbott HIV Antiretroviral Drug Product
 Table 142. Abbott Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 143. Abbott Recent Development
 Table 144. Johnson & Johnson Company Details
 Table 145. Johnson & Johnson Business Overview
 Table 146. Johnson & Johnson HIV Antiretroviral Drug Product
 Table 147. Johnson & Johnson Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 148. Johnson & Johnson Recent Development
 Table 149. Biocon Limited Company Details
 Table 150. Biocon Limited Business Overview
 Table 151. Biocon Limited HIV Antiretroviral Drug Product
 Table 152. Biocon Limited Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 153. Biocon Limited Recent Development
 Table 154. Affine Formulations Limited Company Details
 Table 155. Affine Formulations Limited Business Overview
 Table 156. Affine Formulations Limited HIV Antiretroviral Drug Product
 Table 157. Affine Formulations Limited Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 158. Affine Formulations Limited Recent Development
 Table 159. IPCA Laboratories Company Details
 Table 160. IPCA Laboratories Business Overview
 Table 161. IPCA Laboratories HIV Antiretroviral Drug Product
 Table 162. IPCA Laboratories Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 163. IPCA Laboratories Recent Development
 Table 164. Natco Pharma Company Details
 Table 165. Natco Pharma Business Overview
 Table 166. Natco Pharma HIV Antiretroviral Drug Product
 Table 167. Natco Pharma Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 168. Natco Pharma Recent Development
 Table 169. Beacon Pharmaceuticals Company Details
 Table 170. Beacon Pharmaceuticals Business Overview
 Table 171. Beacon Pharmaceuticals HIV Antiretroviral Drug Product
 Table 172. Beacon Pharmaceuticals Revenue in HIV Antiretroviral Drug Business (2020-2025) & (US$ Million)
 Table 173. Beacon Pharmaceuticals Recent Development
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources
 Table 177. Authors List of This Report


List of Figures
 Figure 1. HIV Antiretroviral Drug Picture
 Figure 2. Global HIV Antiretroviral Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HIV Antiretroviral Drug Market Share by Type: 2024 VS 2031
 Figure 4. Nucleoside Reverse Transcriptase Inhibitors Features
 Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitors Features
 Figure 6. Protease Inhibitors Features
 Figure 7. Fusion Inhibitors Features
 Figure 8. Others Features
 Figure 9. Global HIV Antiretroviral Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global HIV Antiretroviral Drug Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. HIV Antiretroviral Drug Report Years Considered
 Figure 15. Global HIV Antiretroviral Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global HIV Antiretroviral Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global HIV Antiretroviral Drug Market Share by Region: 2024 VS 2031
 Figure 18. Global HIV Antiretroviral Drug Market Share by Players in 2024
 Figure 19. Global Top HIV Antiretroviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Antiretroviral Drug as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by HIV Antiretroviral Drug Revenue in 2024
 Figure 21. North America HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America HIV Antiretroviral Drug Market Share by Country (2020-2031)
 Figure 23. United States HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe HIV Antiretroviral Drug Market Share by Country (2020-2031)
 Figure 27. Germany HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific HIV Antiretroviral Drug Market Share by Region (2020-2031)
 Figure 35. China HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America HIV Antiretroviral Drug Market Share by Country (2020-2031)
 Figure 43. Mexico HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa HIV Antiretroviral Drug Market Share by Country (2020-2031)
 Figure 47. Turkey HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE HIV Antiretroviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. ViiV Healthcare(GlaxoSmithKline) Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 51. Gilead Sciences Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 52. AbbVie Inc. Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 53. Merck & Co Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 54. GSK Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 56. Theratechnologies Inc. Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 57. Roche Holding AG Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 58. Teva Pharmaceuticals Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 59. Pfizer Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 60. Frontier Biotechnologies Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 61. Shionogi Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 62. Julphar Bangladesh Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 63. Mylan Pharmaceuticals Inc. Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 64. Genentech, Inc. Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 65. Boehringer Ingelheim Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 66. Cipla Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 67. MSD Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 68. Abbott Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 69. Johnson & Johnson Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 70. Biocon Limited Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 71. Affine Formulations Limited Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 72. IPCA Laboratories Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 73. Natco Pharma Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 74. Beacon Pharmaceuticals Revenue Growth Rate in HIV Antiretroviral Drug Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global HIV Therapy Drug Market Research Report 2025
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Direct acting Antiviral Drugs Market
Global Oncolytic Virus Drug Treatment Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Retroviral Drugs Market Research Report 2024
Global Ritonavir Drug Market Research Report 2024
Global Pharmaceutical Validation Services Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Global Ophthalmic Anti Infective Drugs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions